2019 International Congress

Tuesday, September 24, 2019

1:45pm-3:15pm

Parkinsonian syndrome associated to C9orf72 expansion

S. Novo Ponte, E. Gamo González, P. Sánchez Alonso (Majadahonda, Spain)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinsonism and rapidly progressive dementia secondary to free-living ameba

M. Rubio Hernandez, I. Rodriguez Leyva, M. Tello Zavala, A. Ortiz Alvarez, C. Gallegos Rios (San Luis Potosi, Mexico)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Parkinsonism in HIV positive persons in South Africa

FH. Amod (Durban, South Africa)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease

R. Moraes, J. Freitas, R. Ferreira, P. Pereira, P. Terzian, F. Godinho, M. Rocha (Sao Paulo, Brazil)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Patients Experiencing Motor Fluctuations With Parkinson’s Disease (PD): Participant Characteristics in the Accordance Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa

P. Lewitt, R. Gendreau, J. Meckler, A. Hotovely-Salomon, N. Navon (West Bloomfield, MI, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Pattern and Presentation of Parkinson Disease in two Teaching Hospitals in Enugu, South East Nigeria

B. Ezeala-Adikaibe (Enugu, Nigeria)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Pediatric Deep Brain Stimulation in Secondary Dystonia using Stereotactic Depth Electrode Targeting

M. Liker, T. Sanger (Los Angeles, CA, USA)

Dystonia  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson’s disease is safe and may be advantageous

F. Baig, L. Mooney, M. Selikhova, M. Rolinski, K. Szewczyk-Krolikowski, N. Collin, A. Whone (Bristol, United Kingdom)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations

P. Campbell, J. Harvey, A. Costantini, H. Morris, A. Schapira (London, United Kingdom)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Pharmacokinetics of ABBV-951 Following 24-Hour Continuous Subcutaneous Infusion to Arm, Abdomen and Thigh

M. Rosebraugh, P. Kym, W. Liu, M. Facheris, J. Benesh (North Chicago, IL, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3